Pharmafile Logo
Pharmafocus logo
Advanced Search

type 1

Showing 6 posts of 6 posts found.

novo

Drug industry suing to overturn Minnesota insulin affordability law

July 2, 2020
Business Services diabetes, insulin, type 1, type 2

The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …

News

Insulin pumps tied to over 2,000 injuries recalled

February 14, 2020
Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes

Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …

News
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

News

NICE changes insulin advice in diabetes guidelines

December 12, 2014
Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2

NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …

News
Afrezza image

Inhaled insulin one step closer to approval

April 3, 2014
Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024